Johnson & Johnson has earned ‘de novo’ approval from the US FDA for what it said is the world’s first table-integrated soft tissue robotic surgical system.

FDA grants De Novo authorization for Johnson & Johnson's OTTAVA robotic surgical system for general surgery procedures.

Johnson & Johnson (J&J) has received marketing authorization from the US Food and Drug Administration (FDA) for its Ottava robotic surgical system, clearing the healthcare major…